ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,399.22
      -0.51%
      US Tech 100
      18,362.80
      -0.93%
      Dow Jones
      39,935.07
      0.20%
      Brent Oil
      81.605
      0.09%
      Bitcoin
      66,934.07
      1.74%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Immutep Ltd (IMMP)

      7. Immutep Ltd (IMMP) News

      IMMP

      Immutep (IMMP)

      Immutep Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IMMP
      DateTimeSourceHeadlineSymbolCompany
      12:00PMiHub NewswireFeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project
      07/22/20248:00AMGlobeNewswire Inc.Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung CancerNASDAQ:IMMPImmutep Ltd
      07/17/20248:00AMGlobeNewswire Inc.Immutep Receives Regulatory Clearance for Phase I Study of First-in-Class LAG-3 Agonist Antibody Designed to Treat Autoimmune DiseasesNASDAQ:IMMPImmutep Ltd
      07/11/20246:40PMGlobeNewswire Inc.Immutep Reports Positive Results in First Line Head and Neck Squamous Cell Carcinoma Patients with Negative PD-L1 ExpressionNASDAQ:IMMPImmutep Ltd
      07/03/20248:00AMGlobeNewswire Inc.Immutep Announces Details for Oral Presentation at ESMO Virtual Plenary Session and Webcast to Discuss Clinical ResultsNASDAQ:IMMPImmutep Ltd
      06/25/20248:00AMGlobeNewswire Inc.Immutep Signs Exclusive License Agreement with Cardiff University for Next Generation Anti-LAG-3 Molecules for CancerNASDAQ:IMMPImmutep Ltd
      06/05/20246:00AMGlobeNewswire Inc.Immutep successfully completes institutional placement and institutional component of entitlement offerNASDAQ:IMMPImmutep Ltd
      06/04/20247:35AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMMPImmutep Ltd
      06/02/20248:38PMGlobeNewswire Inc.Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III TrialNASDAQ:IMMPImmutep Ltd
      05/15/20248:00AMGlobeNewswire Inc.Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024NASDAQ:IMMPImmutep Ltd
      05/02/20248:00AMGlobeNewswire Inc.Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue SarcomaNASDAQ:IMMPImmutep Ltd
      04/29/20248:00AMGlobeNewswire Inc.Immutep Quarterly Activities Report Q3 FY24NASDAQ:IMMPImmutep Ltd
      04/24/20248:00AMGlobeNewswire Inc.Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort BNASDAQ:IMMPImmutep Ltd
      04/18/20248:00AMGlobeNewswire Inc.Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761NASDAQ:IMMPImmutep Ltd
      04/17/20248:00AMGlobeNewswire Inc.Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung CancerNASDAQ:IMMPImmutep Ltd
      03/05/20248:00AMGlobeNewswire Inc.Immutep Announces First Clinical Data from 90mg Dosing of EftiNASDAQ:IMMPImmutep Ltd
      01/30/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMMPImmutep Ltd
      01/30/20248:00AMGlobeNewswire Inc.Immutep Quarterly Activities Report Q2 FY24NASDAQ:IMMPImmutep Ltd
      01/04/20248:00AMGlobeNewswire Inc.First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urothelial CancerNASDAQ:IMMPImmutep Ltd
      12/21/20238:00AMGlobeNewswire Inc.Immutep Receives Constructive Regulatory Feedback on TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung CancerNASDAQ:IMMPImmutep Ltd
      12/21/20236:06AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMMPImmutep Ltd
      12/07/20238:00AMGlobeNewswire Inc.Immutep Receives A$2.6 million R&D Tax Incentive from French GovernmentNASDAQ:IMMPImmutep Ltd
      11/22/20238:00AMGlobeNewswire Inc.Immutep Announces Site Expansion for INSIGHT-003 Phase I TrialNASDAQ:IMMPImmutep Ltd
      11/09/20238:00AMGlobeNewswire Inc.Immutep Completes Enrollment in TACTI-003 Phase IIb Trial of Efti and KEYTRUDA® in First Line Metastatic or Recurrent Head and Neck Squamous Cell CarcinomaNASDAQ:IMMPImmutep Ltd
      11/06/20238:00AMGlobeNewswire Inc.Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast CancerNASDAQ:IMMPImmutep Ltd
      11/03/202312:00PMGlobeNewswire Inc.Immutep Announces New Biomarker Data from TACTI-002 Phase II in First Line Non-Small Cell Lung CancerNASDAQ:IMMPImmutep Ltd
      11/03/20236:06AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMMPImmutep Ltd
      11/02/20238:00AMGlobeNewswire Inc.Immutep to Participate in November Investor EventsNASDAQ:IMMPImmutep Ltd
      10/31/20238:00AMGlobeNewswire Inc.Immutep Quarterly Activities Report Q1 FY24NASDAQ:IMMPImmutep Ltd
      10/25/20238:00AMGlobeNewswire Inc.Immutep receives ~A$1.13 million R&D Tax IncentiveNASDAQ:IMMPImmutep Ltd
       Showing the most relevant articles for your search:NASDAQ:IMMP

      Your Recent History

      TG
      A1ZVXC
      Apple
      Delayed Upgrade Clock